{"status": "OK", "response": {"docs": [{"type_of_material": "Op-Ed", "blog": [], "news_desk": "Editorial Desk", "lead_paragraph": "Politicians from both political parties, who ought to know better, are putting pressure on the Drug Enforcement Administration to make a decision that would harm many young children and teen-agers. It's not clear whether the politicians know all the facts -- or even whose interests they are representing. An odd political alliance of more than 140 Republicans and Democrats -- from Edward M. Kennedy and Barbara Boxer to Jesse Helms and Strom Thurmond -- is supporting a petition that seeks to loosen the rules governing the prescription drug methlyphenidate, better known by its trade name, Ritalin.", "headline": {"main": "Reading, Writing and Ritalin"}, "abstract": null, "print_page": "21", "word_count": 773, "_id": "4fd1d4d18eb7c8105d712811", "snippet": "Politicians from both political parties, who ought to know better, are putting pressure on the Drug Enforcement Administration to make a decision that  would harm many young children and teen-agers. It's not clear whether the politicians know all the...", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/1995/10/21/opinion/reading-writing-and-ritalin.html", "multimedia": [], "subsection_name": null, "keywords": [{"name": "persons", "value": "KENNEDY, EDWARD M"}, {"name": "persons", "value": "BOXER, BARBARA"}, {"name": "persons", "value": "THURMOND, STROM"}, {"name": "persons", "value": "HELMS,JESSE"}, {"name": "organizations", "value": "CIBA-GEIGY CORP DRUG ENFORCEMENT ADMINISTRATION"}, {"name": "subject", "value": "ATTENTION DEFICIT HYPERACTIVITY DISORDER (ADD)"}, {"name": "subject", "value": "EDUCATION AND SCHOOLS"}, {"name": "subject", "value": "CHILDREN AND YOUTH"}, {"name": "subject", "value": "RITALIN (DRUG)"}, {"name": "subject", "value": "REGULATION AND DEREGULATION OF INDUSTRY"}], "byline": {"person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "John", "lastname": "Merrow"}], "original": "By John Merrow"}, "document_type": "article", "pub_date": "1995-10-21T00:00:00Z", "section_name": "Health; Opinion"}, {"type_of_material": "Chronology", "blog": [], "news_desk": "National Desk", "lead_paragraph": "House Republicans took a giant step today toward dismantling decades of Democratic social policy, passing legislation to curb Medicare spending and encourage the elderly to turn to private managed-care organizations from the traditional Government plan that has served them since 1965. The vote was 231 to 201, as 4 Democrats joined 227 Republicans in favor of the bill, while 6 Republicans, 194 Democrats and 1 independent voted against it.", "headline": {"main": "HOUSE VOTES TO CURB COSTS OF MEDICARE BY $270 BILLION; PRESIDENT PROMISES A VETO", "kicker": "RESHAPING MEDICARE: THE OVERVIEW"}, "abstract": null, "print_page": "1", "word_count": 1432, "_id": "4fd1d17e8eb7c8105d70c0fc", "snippet": "House Republicans took a giant step today toward dismantling decades of Democratic social policy, passing legislation to curb Medicare spending and encourage the elderly to turn to private managed-care organizations from the traditional Government...", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/1995/10/20/us/reshaping-medicare-overview-house-votes-curb-costs-medicare-270-billion.html", "multimedia": [], "subsection_name": null, "keywords": [{"name": "persons", "value": "CLINTON, BILL"}, {"name": "persons", "value": "GINGRICH, NEWT"}, {"name": "glocations", "value": "UNITED STATES"}, {"name": "organizations", "value": "MEDICARE"}, {"name": "subject", "value": "HEALTH MAINTENANCE ORGANIZATIONS"}, {"name": "subject", "value": "FINANCES"}, {"name": "subject", "value": "MEDICARE"}, {"name": "subject", "value": "MEDICINE AND HEALTH"}, {"name": "subject", "value": "LAW AND LEGISLATION"}, {"name": "subject", "value": "BUDGETS AND BUDGETING"}], "byline": {"person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "Adam", "lastname": "CLYMER"}], "original": "By ADAM CLYMER"}, "document_type": "article", "pub_date": "1995-10-20T00:00:00Z", "section_name": "Front Page; Health; U.S."}, {"type_of_material": "Biography", "blog": [], "news_desk": "Science Desk", "lead_paragraph": "AT the age of 70, and still making scientific discoveries, Dr. Oliver Smithies of the University of North Carolina in Chapel Hill, has had a long career studded with startling results. But one moment stands out: a sudden insight into the glories and uncertainties of research that perfectly describes why he so loves to do experiments. It was the morning of May 18, 1985, three years and one month after Dr. Smithies had begun his quest to insert genes into specified positions in cellular DNA. If he succeeded in this \"gene targeting,\" it would be a remarkable achievement, making possible the creation of diseases like cystic fibrosis and atherosclerosis in laboratory animals, allowing scientists to test drugs and prevention strategies and to understand the genetic basis of disease. But it was risky and uncertain. In fact, at one point Dr. Smithies's students gave up on the project, saying they were going on to other things.", "headline": {"main": "SCIENTIST AT WORK: Oliver Smithies;Sprinting Along for Five Decades"}, "abstract": null, "print_page": "1", "word_count": 1822, "_id": "4fd1ec478eb7c8105d73d35d", "snippet": "AT the age of 70, and still making scientific discoveries, Dr. Oliver Smithies of the University of North Carolina in Chapel Hill, has had a long career studded with startling results. But one moment stands out: a sudden insight into the glories and...", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/1995/10/17/science/scientist-at-work-oliver-smithies-sprinting-along-for-five-decades.html", "multimedia": [], "subsection_name": null, "keywords": [{"name": "persons", "value": "SMITHIES, OLIVER"}, {"name": "organizations", "value": "UNIVERSITY OF NORTH CAROLINA"}, {"name": "subject", "value": "BIOGRAPHICAL INFORMATION"}, {"name": "subject", "value": "BIOLOGY AND BIOCHEMISTRY"}, {"name": "subject", "value": "RESEARCH"}], "byline": {"person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "Gina", "lastname": "KOLATA"}], "original": "By GINA KOLATA"}, "document_type": "article", "pub_date": "1995-10-17T00:00:00Z", "section_name": "Science; Health"}, {"type_of_material": "News", "blog": [], "news_desk": "National Desk", "lead_paragraph": "Embedded in the vast legislation to overhaul Medicare and Medicaid are a series of narrowly focused, widely overlooked provisions that would relax Federal regulation of doctors and their laboratories, reimburse private hospitals for some local taxes and grant benefits potentially worth hundreds of millions of dollars to manufacturers of prescription drugs and medical devices. The legislation would broadly reshape health care for millions of Americans. But in its fine print, it also serves as a vehicle for proposals pushed by segments of the health care industry, which have mobilized a small army of lobbyists to press their concerns. Republicans defend these measures, saying consumers will benefit if Congress lifts the heavy hand of Federal regulation from the industry.", "headline": {"main": "BENEATH SURFACE, HEALTH CARE PLAN IS OFFERING BOONS"}, "abstract": null, "print_page": "1", "word_count": 2419, "_id": "4fd1cf0c8eb7c8105d707832", "snippet": "Embedded in the vast legislation to overhaul Medicare and Medicaid are a series of narrowly focused, widely overlooked provisions that would relax Federal regulation of doctors and their laboratories, reimburse private hospitals for some local taxes...", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/1995/10/15/us/beneath-surface-health-care-plan-is-offering-boons.html", "multimedia": [], "subsection_name": null, "keywords": [{"name": "glocations", "value": "UNITED STATES"}, {"name": "organizations", "value": "AMERICAN MEDICAL ASSN"}, {"name": "organizations", "value": "MEDICARE"}, {"name": "subject", "value": "TAXATION"}, {"name": "subject", "value": "DRUGS (PHARMACEUTICALS)"}, {"name": "subject", "value": "MEDICAID"}, {"name": "subject", "value": "MEDICARE"}, {"name": "subject", "value": "DOCTORS"}, {"name": "subject", "value": "CONSUMER PROTECTION"}, {"name": "subject", "value": "MEDICINE AND HEALTH"}, {"name": "subject", "value": "LAW AND LEGISLATION"}, {"name": "subject", "value": "LOBBYING AND LOBBYISTS"}, {"name": "subject", "value": "HOSPITALS"}, {"name": "subject", "value": "REGULATION AND DEREGULATION OF INDUSTRY"}], "byline": {"person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "Martin", "lastname": "GOTTLIEB"}, {"organization": "", "role": "reported", "rank": 2, "firstname": "Robert", "lastname": "PEAR"}], "original": "By MARTIN GOTTLIEB and ROBERT PEAR"}, "document_type": "article", "pub_date": "1995-10-15T00:00:00Z", "section_name": "Health; U.S."}], "meta": {"hits": 4, "offset": 0, "time": 28}}, "copyright": "Copyright (c) 2013 The New York Times Company.  All Rights Reserved."}